Sydnexis

1 follower


Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

Employees

11-50

Links


Org chart

Ken Widder
CEO & Strategic Advisor
Collapse
Nick Ruth
Chief Commercial Officer
Linda Gieschen
VP, Program Management
Ken Laderman
VP & Head, Manufacturing
Tim Murphy
Senior Director, Project Management

Board & advisors